FDA advises caution for gene therapy trials
At a recent meeting, the FDA advised a cautious approach for gene therapy trials. The two day CTGTAC meeting discussed the toxicity...
top of page
News
Search
Sep 8, 2021
BioMarin AAV gene therapy trial halted
The FDA has halted testing of BioMarin's AAV based gene therapy drug after liver cancer developed in treated mice. BioMarin's BMN_307...
Sep 7, 2021
CSO presented at CTGTAC
The Cellular, Tissue and Gene Therapies Advisory Committee held a virtual public meeting meeting on 2-3rd September on the toxicity risks...
Sep 7, 2021
AAV Integration Roundtable
The ASGCT sponsored a roundtable event of talks by industry experts on AAV integration. These discussions were extremely interesting and...
Aug 31, 2021
We have a new Principal Scientist
Saqlain Suleman has joined the TestAVec team as Principal Scientific Officer. He will be working to develop and lead projects in...
bottom of page